Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
Depreciation & Amortization
Aurisco Pharmaceutical Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Depreciation & Amortization
-¥25.2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Depreciation & Amortization
-¥43.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-25.2m
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Depreciation & Amortization amounts to -25.2m CNY.
What is Aurisco Pharmaceutical Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-33%
Over the last year, the Depreciation & Amortization growth was -22%. The average annual Depreciation & Amortization growth rates for Aurisco Pharmaceutical Co Ltd have been -40% over the past three years , -33% over the past five years .